Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 10:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 126 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of Toronto Clear all

Conditions: Posttraumatic Stress Disorder, Borderline Personality Disorder
Interventions: Cognitive Processing Therapy with Suicide Risk Management, Treatment as Usual with Suicide Rick Management; Behavioral
Lead sponsor: Palo Alto University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Parkinson Disease
Interventions: Lumbar Puncture; Procedure
Lead sponsor: Michael J. Fox Foundation for Parkinson's Research; Other
Eligibility: 30 Years and older
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Chicago, Illinois • New York, New York • Portland, Oregon + 1 more

Conditions: Scoliosis
Interventions: Surgical intervention, Non-operative intervention; Procedure · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years to 80 Years
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 7
States / cities: Chicago, Illinois • Louisville, Kentucky • Baltimore, Maryland + 3 more

Conditions: Amyotrophic Lateral Sclerosis, Parkinson Disease, Dysphagia
Interventions: Videofluoroscopic Swallowing Examination, Tongue Strength Measurement; Diagnostic Test · Other
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Interventions: Not listed
Lead sponsor: University of Alberta; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2026
U.S. locations: 2
States / cities: Miami, Florida • Salt Lake City, Utah

Conditions: Lung Transplant, Organ Preservation
Interventions: Lung transplantation after 10°C donor lung preservation, Lung transplantation after standard ice cooler donor lung preservation; Device
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years to 80 Years
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: Phoenix, Arizona • San Francisco, California • Coral Gables, Florida + 4 more

Conditions: ARDS
Interventions: Respiratory Mechanics, Standard Ventilation Strategy; Other
Lead sponsor: Unity Health Toronto; Other
Eligibility: 18 Years and older
Enrollment: 740 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Psoriatic Arthritis
Interventions: Ultrasound; Device
Lead sponsor: Ottawa Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Anal Squamous Cell Carcinoma
Interventions: Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy - Intermediate risk group, Radiotherapy - High risk group; Radiation
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Milwaukee, Wisconsin

Conditions: Seasonal Affective Disorder
Interventions: Negative Ion Generator, Light-emitting Photodiode light treatment device; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 3
States / cities: New Haven, Connecticut • Rockville, Maryland • Belmont, Massachusetts

Conditions: Diabetic Nephropathies, Coronary Artery Disease
Interventions: Allopurinol, Placebo; Drug
Lead sponsor: Alessandro Doria; Other
Eligibility: 18 Years to 70 Years
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 23
States / cities: Aurora, Colorado • Denver, Colorado • Atlanta, Georgia + 15 more

Conditions: Sickle Cell Disease, Chronic Pain
Interventions: cognitive behavioral therapy, eEducation; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pain, Chronic, Pain, Joint Pain, Musculoskeletal Pain
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 11 Years to 18 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Palo Alto, California • Cincinnati, Ohio

Conditions: PSP - Progressive Supranuclear Palsy, PD - Parkinson's Disease, AD - Alzheimer's Disease, ALS (Amyotrophic Lateral Sclerosis)
Interventions: Pupillometry; Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 55 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Perinatal Depression
Interventions: Brief Behavioral Activation Treatment; Behavioral
Lead sponsor: Mount Sinai Hospital, Canada; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Evanston, Illinois • Chapel Hill, North Carolina

Conditions: Hypertrophic Cardiomyopathy (HCM)
Interventions: None - observational study; Other
Lead sponsor: Christopher Kramer; Other
Eligibility: 18 Years to 65 Years
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 6
States / cities: Boston, Massachusetts • Medford, Massachusetts • Ann Arbor, Michigan + 3 more

Conditions: Knee Dislocations, Multiple Ligament Knee Injuries
Interventions: Early Surgery, Delayed Surgery, Early Rehab, Delayed Rehab; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 16 Years to 55 Years
Enrollment: 690 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Aortic Stenosis, Cardiac Valve Replacement Complication, Fragility
Interventions: Not listed
Lead sponsor: Jewish General Hospital; Other
Eligibility: 70 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 4
States / cities: Boston, Massachusetts • Durham, North Carolina

Conditions: Very Low Birth Weight Baby, Early Nutrition and the Preterm Infant, Nutritional Requirements, Human Milk Fortification, Human Milk Microbiome, Human Milk Feeding, Human Milk Nutrition, Growth &Amp; Development
Interventions: Opti-NuM is an observational secondary use of data/samples study, the investigators will analyze information and specimens from the MaxiMoM platform RCTs. No interventions form part of this study.; Other
Lead sponsor: The Hospital for Sick Children; Other
Eligibility: 1 Hour to 21 Days
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 2
States / cities: Palo Alto, California • San Diego, California

Conditions: DiGeorge Syndrome, 22q11.2 Deletion Syndrome
Interventions: Not listed
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Bipolar Disorder, Cognitive Impairment
Interventions: Quetiapine XR, Placebo; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Atlanta, Georgia • Durham, North Carolina

Conditions: Competence, Assessment, Self
Interventions: EMR STAT - Survey; Behavioral
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Pregnancy, Childbirth and the Puerperium
Interventions: Repeated hands-and-knees positioning during labour; Other
Lead sponsor: University of Toronto; Other
Eligibility: Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Psychotic Depression
Interventions: Sertraline + Olanzapine, Sertraline + Placebo; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 269 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 3
States / cities: Worcester, Massachusetts • White Plains, New York • Pittsburgh, Pennsylvania

Search by objective public record fields.

Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder and Borderline Personality Disorder (PTSD-BPD)

FoxBioNet: ECV (Extracellular Vesicle) 004

A Multicenter Prospective Study of Quality of Life in Adult Scoliosis

Physiological Flow of Liquids Used in Dysphagia Management (Neuro)

Novel MRI Biomarkers for Monitoring Disease Progression in ALS

10°C vs 4°C Lung Preservation RCT

Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)

Validation of Handheld Ultrasound Devices in Rheumatology

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes

Computerized Cognitive Behavioral Therapy Assisted Life Management for Pain in Sickle Cell Disease

SPRINT: Signature for Pain Recovery IN Teens

Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)

HCMR Re-Imaging Study

STaR Trial: Multiple Ligament Knee Injuries

Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions

Optimizing Nutrition and Milk (Opti-NuM) Project

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder

Evaluating Learning Curves and Competence in Colorectal Endoscopic Mucosal Resection Among Advanced Endoscopy Trainees

A Pilot Randomized Controlled Trial of Repeated Hands-and-Knees Positioning During Labour

Sustaining Remission of Psychotic Depression